Evidence map›Paper›PMID 21987759›Full record

ArticleThe Journal of infectious diseases2011

Unconventional secretion of Ebola virus matrix protein VP40.

Olivier Reynard, St Patrick Reid, Audrey Page, Mathieu Mateo, Nathalie Alazard-Dany, Hervé Raoul, Christopher F Basler, Viktor E Volchkov

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Secreted Nonstructural Protein 3 is a Pathogenic Determinant of Orbivirus.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Extracellular vesicle storm during the course of Ebola virus infection in primates.Frontiers in cellular and infection microbiology · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Olivier ReynardFilovirus Laboratory, Inserm U758, Human Virology Department, Université de Lyon, Ecole Normale Supérieure de Lyon, Lyon, France.
St Patrick Reid
Audrey Page
Mathieu Mateo
Nathalie Alazard-Dany
Hervé Raoul
Christopher F Basler
Viktor E Volchkov

Funding

Ebola VP35 Interferon-Antagonist: Mechanism and SignifR01AI059536 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BASLER, CHRISTOPHER F · 2005 to 2015
$4.2M
NIAID NIH HHS AI059536NIAID NIH HHS R01 AI059536
6 · The paper itself

Abstract

The Ebola virus matrix protein VP40 plays an essential role in virus assembly and budding. In this study we reveal that transient VP40 expression results in the release into the culture medium of substantial amounts of soluble monomeric VP40 in addition to the release of virus-like particles containing an oligomeric form of this protein as previously described. We show that VP40 secretion is endoplasmic reticulum/Golgi-independent and is not associated with cell death. Soluble VP40 was observed during Ebola virus infection of cells and was also found in the serum of virus-infected animals albeit in lower amounts. Unconventional secretion of VP40 may therefore play a role in Ebola virus pathogenicity.

Indexed as

AnimalsChlorocebus aethiopsCulture MediaEbolavirusEndoplasmic ReticulumGene Expression Regulation, ViralGolgi ApparatusHEK293 CellsHumansVero CellsViral Matrix ProteinsCulture MediaViral Matrix ProteinsVP40 protein, virus

Identifiers

PMID21987759
PMCPMC3189981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.